Two studies, in which a large number of breast tumors were used, demonstrated that ZNF703 meets the criteria as the genetic driver of the A1 amplicon, emerging as a gene with an oncogenic role in luminal B type breast cancer 16–17. This evidence concerns the gene ZNF703 and breast neoplasm.